Skip to main content
Home HBM Healthcare Investments

Side Nav [EN]

  • Contact
  • Twitter
  • English
  • Deutsch
  • Company
    • Profile
    • Team
    • Invest in HBM
    • Contact
  • Sector
  • Portfolio
    • Portfolio overview
    • Significant investments
    • Investment Strategy
    • Sustainability
  • Investors
    • Share/NAV
    • Financial Reports
    • Information
    • Shareholders’ Meeting
    • Calendar
  • News
Home HBM Healthcare Investments

Side Nav [EN]

  • Contact
  • Twitter
  • English
  • Deutsch
  • Company
    • Profile
    • Team
    • Invest in HBM
    • Contact
  • Sector
  • Portfolio
    • Portfolio overview
    • Significant investments
    • Investment Strategy
    • Sustainability
  • Investors
    • Share/NAV
    • Financial Reports
    • Information
    • Shareholders’ Meeting
    • Calendar
  • News
Upstream Bio

Upstream Bio

Anti-TSLP receptor mAB for the treatment of severe asthma and other chronic inflammation diseases.


 
Upstream Bio Website
  Significant investments Overview

Subscribe to news service

Credits
Important legal information
Cookies Policy
Privacy Notice

© 2023 HBM Healthcare Investments
Copyright reserved